ReviewTherapeutic advances in urology2015

Clinical use of the β3 adrenoceptor agonist mirabegron in patients with overactive bladder syndrome.

Monika Vij et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.